BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $535,833 | -56.8% | 14,198 | -47.9% | 0.06% | -55.8% |
Q2 2023 | $1,241,373 | +31.1% | 27,247 | +16.7% | 0.14% | +23.2% |
Q1 2023 | $947,117 | -2.7% | 23,351 | +22.3% | 0.11% | -13.2% |
Q4 2022 | $973,527 | -13.2% | 19,100 | -8.3% | 0.13% | -21.3% |
Q3 2022 | $1,122,000 | -4.3% | 20,830 | +14.2% | 0.16% | +0.6% |
Q2 2022 | $1,172,000 | -16.8% | 18,241 | +0.4% | 0.16% | -4.7% |
Q1 2022 | $1,409,000 | -4.0% | 18,173 | +6.4% | 0.17% | -10.0% |
Q4 2021 | $1,467,000 | +6.9% | 17,084 | +0.2% | 0.19% | -2.6% |
Q3 2021 | $1,372,000 | +9.7% | 17,058 | +9.8% | 0.20% | +4.3% |
Q2 2021 | $1,251,000 | +52.6% | 15,538 | +59.8% | 0.19% | -14.2% |
Q1 2021 | $820,000 | +20.2% | 9,726 | +14.4% | 0.22% | +18.5% |
Q4 2020 | $682,000 | – | 8,501 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |